Literature DB >> 2531756

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.

R N Jones1, T L Gavan, C Thornsberry, P C Fuchs, E H Gerlach, J S Knapp, P Murray, J A Washington.   

Abstract

A six-laboratory study developed a standardized method for determining the susceptibilities of Neisseria gonorrhoeae strains to penicillin, tetracycline, spectinomycin, and ceftriaxone. Three quality control organisms were also selected, and quality assurance guidelines were initially generated for the disk diffusion and agar dilution methods. The medium recommended for gonococcal susceptibility testing was GC agar with a defined "XV-like" supplement. The supplement should be free of cysteine, a component implicated in the inactivation of some newer beta-lactam compounds. Penicillin, tetracycline, spectinomycin, and ceftriaxone were stable in agar plates stored at 3 to 5 degrees C for at least 2 weeks. Numerous GC agar and drug disk lots were used during the trials without significant variation in test results. Several other gonococcal strains were recommended for additional medium quality assurance. The disk quality control zone limits were established for N. gonorrhoeae ATCC 49226 (formerly CDC F-18) and Staphylococcus aureus ATCC 25923. MIC quality control ranges were also developed for N. gonorrhoeae ATCC 49226 and S. aureus ATCC 29213. The interpretive criteria for penicillin were as follows: susceptibility, greater than or equal to 47 mm (diameter of inhibition zone) (less than or equal to 0.06 micrograms/ml [MIC]); resistance, less than or equal to 26 mm (greater than or equal to 2 micrograms/ml). For tetracycline they were as follows: susceptibility, greater than or equal to 38 mm (less than or equal to 0.25 microgram/ml); resistance, less than or equal to 30 mm (greater than or equal to 2 micrograms/ml). For spectinomycin they were as follows: susceptibility, >/= 18 mm (</= 32 micrograms/ml); resistance, </= 14 mm (>/= 128 micrograms/ml). For ceftriaxone susceptibility, the criterion was >/= 35 mm (</= 0.25 micrograms/ml) with no other category. Criteria of </= 19 mm for plasmid-mediated resistances to penicillin and tetracycline were also confirmed. The false-susceptibility errors were </= 1% with these criteria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531756      PMCID: PMC267122          DOI: 10.1128/jcm.27.12.2758-2766.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  Effects of penicillin, streptomycin, and tetracycline on N. gonorrhoeae isolated in 1944 and in 1957.

Authors:  A REYN; B KORNER; M W BENTZON
Journal:  Br J Vener Dis       Date:  1958-12

Review 2.  Beta-lactamase plasmids and chromosomally mediated antibiotic resistance in pathogenic Neisseria species.

Authors:  J A Dillon; K H Yeung
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

3.  High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant.

Authors:  S A Morse; S R Johnson; J W Biddle; M C Roberts
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

4.  Chromosomally mediated resistance in Neisseria gonorrhoeae in the United States: results of surveillance and reporting, 1983-1984.

Authors:  R J Rice; J W Biddle; Y A JeanLouis; W E DeWitt; J H Blount; S A Morse
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

5.  Penicillin-insensitive Neisseria meningitidis.

Authors:  M S Sprott; A M Kearns; J M Field
Journal:  Lancet       Date:  1988-05-21       Impact factor: 79.321

6.  Tetracycline-resistant gonococci in UK.

Authors:  C A Ison; P Terry; K Bendayna; M J Gill; J Adams; N Woodford
Journal:  Lancet       Date:  1988-03-19       Impact factor: 79.321

7.  Antimicrobial agent resistance in Neisseria gonorrhoeae in St. Paul Minnesota.

Authors:  R T Lally; B F Woolfrey; M E Gresser-Burns; K Henry
Journal:  Diagn Microbiol Infect Dis       Date:  1988-05       Impact factor: 2.803

8.  Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.

Authors:  A L Barry; T L Gavan; R N Jones; L W Ayers; P C Fuchs; E H Gerlach; C Thornsberry
Journal:  Diagn Microbiol Infect Dis       Date:  1987-05       Impact factor: 2.803

9.  Spread of Neisseria gonorrhoeae resistant to tetracycline outside the United States of America.

Authors:  M A Waugh; C J Lacey; P M Hawkey; J Heritage; A Turner; A E Jephcott
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

10.  A comparison of penicillin G plus a beta-lactamase inhibitor (sulbactam) with spectinomycin for treatment of urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

Authors:  S R Crider; M E Kilpatrick; W O Harrison; S B Kerbs; S W Berg
Journal:  Sex Transm Dis       Date:  1984 Oct-Dec       Impact factor: 2.830

View more
  32 in total

1.  Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.

Authors:  M E Erwin; R N Jones
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines.

Authors:  T E Clendennen; C S Hames; E S Kees; F C Price; W J Rueppel; A B Andrada; G E Espinosa; G Kabrerra; F S Wignall
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

3.  Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae.

Authors:  S Ringertz; M Rylander; G Kronvall
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

4.  The epidemiology of Neisseria gonorrhoeae isolates in Dakar, Sénégal 1982-1986: antimicrobial resistance, auxotypes and plasmid profiles.

Authors:  I Lind; M Arborio; M W Bentzon; Y Buisson; M Guibourdenche; K Reimann; J Y Riou
Journal:  Genitourin Med       Date:  1991-04

5.  Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from the United States and Southeast Asia.

Authors:  S D Putnam; B S Lavin; J R Stone; E C Oldfield; D G Hooper
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

6.  Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin.

Authors:  A L Barry; M A Cohen; J C Sesnie; P C Fuchs; J A Washington; P R Murray; C Baker
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

7.  Incidence of Neisseria gonorrhoeae isolates negative by Syva direct fluorescent-antibody test but positive by Gen-Probe accuprobe test in a sexually transmitted disease clinic population.

Authors:  J L Beebe; M P Rau; S Flageolle; B Calhoon; J S Knapp
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Cocaine hydrochloride and benzoylecgonine have no in vitro inhibitory effect against Neisseria gonorrhoeae.

Authors:  J M Zenilman; C A Reichart; T M Neumann; E W Hook
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters.

Authors:  T Fekete; J Woodwell; K R Cundy
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

10.  Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.

Authors:  H S Sader; R N Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.